Australis Science赢得175 000美元, 因为它的非侵入性智能补丁 治疗失禁, 现在在人类试验中。 Australis Scientific won $175,000 for its non-invasive smart patch treating incontinence, now in human trials.

以悉尼为基地的一家医疗技术公司Australis Science赢得了MedTech创新者亚太大奖,表彰其ConfidanzTM智能补丁,这是一种可磨损的装置,它使用提质神经刺激来治疗过活性膀胱和失禁症。 Australis Scientific, a Sydney-based medical tech company, won the MedTech Innovator Asia Pacific Grand Prize for its ConfidanzTM smart patch, a wearable device using tibial nerve stimulation to treat overactive bladder and incontinence. 在脚踝附近穿戴的这个补丁提供了一种非侵入性的家庭治疗选择。 The patch, worn near the ankle, offers a non-invasive, at-home therapy option. 该公司由哈佛医学院研究员Nick Agahari领导,获得了175 000美元的资金和表彰。 The company, led by Harvard Medical School Fellow Nick Agahari, received $175,000 in funding and recognition. 它目前正在试验SPARC研究中的装置,这是在悉尼和布里斯班举行的第一次人类审判,目的是支持澳大利亚、美国和日本提交管制文件。 It is currently testing the device in the SPARC Study, a first-in-human trial in Sydney and Brisbane, to support regulatory submissions in Australia, the U.S., and Japan. 该奖项来自来自25个国家的300多个参赛者的全球竞争。 The award comes from a global competition with over 300 entries from 25 countries.